Status:
RECRUITING
Star Homes Project 2
Lead Sponsor:
University of Oxford
Collaborating Sponsors:
Mahidol Oxford Tropical Medicine Research Unit
CSK Research Solutions
Conditions:
Malaria
Respiratory Tract Infection Acute
Eligibility:
All Genders
Up to 12 years
Phase:
NA
Brief Summary
Malaria, pneumonia and diarrhoea causes a lot of illness in children in Tanzania and the study want to find better ways of protecting people against these diseases and want to find out if the type of ...
Detailed Description
The study hypothesis is that healthy houses will reduce the incidence of malaria, respiratory diseases and diarrhoeal diseases in children compared with traditional houses. And healthy houses are also...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Main study
- Children, aged under 13 years old, male or female
- Residing in a study village for at least 3 years
- Parents/guardian is willing and able to give written informed consent for the child to participate in the baseline and end-of study evaluation and the surveillance for malaria, respiratory tract infection and diarrhoeal disease.
- Additionally, children 10, 11, and 12 years of age provide assent to participate.
- Ancillary studies
- Head of a household or other family member of a household that is taking part in the main study
- 18 years and above
- Consent to take part in the main study
- Residing and live in the village for 3 years or more
- Live in the intervention or comparison houses or a trusted community member (community leaders, medical officer and community health worker)
- Exclusion criteria
- Main study
- Any participant who refuses, or in the case of children whose parents/guardian refuses, to participate in the study.
- Any child who is between 10 and 12 years who refuses to provide assent
- If the family plans for moving to other village during the study period
- Parents/guardians have mental health problems
- Ancillary studies
- Under 18 years
- Not provide consent
- Not living in the study village for 3 years or more
Exclusion
Key Trial Info
Start Date :
January 4 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
2750 Patients enrolled
Trial Details
Trial ID
NCT04529434
Start Date
January 4 2022
End Date
December 31 2025
Last Update
June 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CSK Research Solutions
Dar Es Salaam, Mtwara, Tanzania